The European Ccommission approves Avzivi, a biosimilar referencing bevacizumab – Bio Thera Solutions
The European Medicines Agency (EMA) has approved Avzivi (BAT 1706), a biosimilar referencing bevacizumab (Avastin), according to an announcement from Bio-Thera Solutions. Avzivi is intended for the treatment… read more.
